Indo Rama Synthetics (India) Q2 FY27 PAT Rises 202% Year-on-Year
Key highlights
- Indo Rama reported Q2 FY27 revenue of ₹1,340.6 crore, up 9.8% year-on-year.
- Q2 FY27 EBITDA rose 46% year-on-year to ₹117.7 crore, with an 8.8% margin.
- Q2 FY27 profit after tax increased 202% year-on-year to ₹74.1 crore.
- Indo Rama has outlined a ₹200 crore specialty expansion plan.
powered by IRIS

Indo Rama Synthetics (India) Ltd reported a 202% year-on-year increase in Q2 FY27 profit after tax to ₹74.1 crore, supported by a 46% rise in EBITDA to ₹117.7 crore and an EBITDA margin of 8.8%. The quarterly performance indicates a sharp recovery in profitability even as first-half revenue remained lower year-on-year.
Know Indo Rama Synthetics (India) inside out
Results, valuation, peers and who's buying, in one view.
What did Indo Rama report for Q2 FY27?
Indo Rama reported Q2 FY27 revenue of ₹1,340.6 crore, up 9.8% year-on-year, while EBITDA rose 46% year-on-year to ₹117.7 crore. The company recorded an EBITDA margin of 8.8% for the quarter, and profit after tax rose 202% year-on-year to ₹74.1 crore.
The figures were included in the company's Q2 FY27 investor presentation, filed on October 23, 2026. The presentation described strong earnings recovery and operational momentum during the quarter. The board had approved the unaudited financial results for the quarter ended September 30, 2026, at its meeting on October 16, 2026.
How did the Q2 FY27 earnings call unfold?
Indo Rama held its Q2 FY27 earnings conference call on October 26, 2026, at 4:00 pm IST to discuss its unaudited financial results. The company subsequently informed the NSE that the audio recording of the call had been uploaded and was available on its website.
The exchange disclosure was made under Regulation 30 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements rules. Ashok Yadav, the company's Company Secretary and Compliance Officer, signed the communication regarding the recording's availability.
The specific announcement on the audio recording did not contain additional financial data, fresh guidance details, or a transcript of management remarks. However, the available call summary indicated that management guided for 15% growth. The source material does not specify the financial or operational measure to which this growth guidance relates.
Why did Indo Rama's profit grow faster than revenue?
Indo Rama's reported earnings growth outpaced its revenue growth in Q2 FY27. Revenue increased 9.8%, whereas EBITDA increased 46% and profit after tax increased 202%, alongside an 8.8% EBITDA margin. This gap shows that the quarterly recovery was driven by improved profitability metrics as well as higher revenue.
The call summary described the company as stabilising after major capacity expansions, with margins expanding. No detailed cost break-up, product-wise volume data, realisation data, or segment-level profitability figures were included in the supplied material. Therefore, the reported figures establish the direction of improvement but do not quantify the separate contribution of costs, product mix, prices, or capacity utilisation.
For investors, the margin figure is an important measure because it compares operating earnings with revenue. At ₹117.7 crore, EBITDA represented 8.8% of Q2 FY27 revenue. The rise in PAT to ₹74.1 crore also marked a stronger percentage increase than the rise in operating earnings, based on the disclosed year-on-year comparisons.
Got a follow-up? Ask IRIS
What is Indo Rama planning after its capacity expansion?
Indo Rama has outlined a ₹200 crore specialty expansion plan, according to its Q2 FY27 investor presentation. The presentation also noted that the company was operating after a period of major capacity additions, while the call summary referred to a phase of stabilisation.
The provided material does not disclose the timeline for the ₹200 crore specialty expansion, the capacity to be added, funding arrangements, or expected revenue contribution. These details will be relevant to assessing the project's execution requirements and its eventual role in the company's operating profile.
The expansion plan comes alongside an uneven first-half revenue picture. While Q2 FY27 revenue rose 9.8% year-on-year, H1 FY27 revenue was down by about 10%, according to the investor presentation summary. This means the Q2 improvement occurred within a first half that remained lower on revenue than the comparable period a year earlier.
How does the Q2 update matter to investors and operations?
Indo Rama's Q2 FY27 update matters because the company reported higher revenue, a 46% increase in EBITDA, and a 202% increase in PAT while pursuing a ₹200 crore specialty expansion. The disclosed data shows an improvement in quarterly operating profitability, although the first-half revenue comparison remained negative.
For shareholders, the available call recording provides access to management's discussion of the quarterly results and strategy. The regulatory filing confirms that the call was held and that its recording was made available, but the filing itself does not add financial guidance beyond the information already indicated in the broader source material.
For operations, the company is balancing stabilisation after previous capacity additions with a further specialty-focused investment plan. The next disclosed financial updates may provide more information on the planned expansion's schedule, the pace of revenue recovery across the first half, and whether the Q2 margin level is sustained.
Conclusion
Indo Rama delivered a substantially stronger Q2 FY27 profit outcome, with PAT rising 202% to ₹74.1 crore, EBITDA increasing 46% to ₹117.7 crore, and revenue growing 9.8% to ₹1,340.6 crore. The improvement in quarterly margins and earnings stands out against the approximately 10% decline reported in H1 FY27 revenue.
The next areas to watch are management's clarification on its stated 15% growth guidance and disclosures on the ₹200 crore specialty expansion, including its timing, capacity scope and funding. Investors will also look for subsequent results to assess whether the Q2 FY27 profitability trend continues.


